To further confirm this result, our data mining using public data sets indicated that DDX52 expression was higher in advanced PCa (metastatic tumors) than in the normal or primary counterparts (Fig. 1c, d) [10, 11]. This evidence concerns the gene DDX52 and posterior cortical atrophy.